[go: up one dir, main page]

NL8402904A - De bloedstolling remmend eiwitmateriaal, werkwijze voor het isoleren daarvan alsmede farmaceutisch preparaat. - Google Patents

De bloedstolling remmend eiwitmateriaal, werkwijze voor het isoleren daarvan alsmede farmaceutisch preparaat. Download PDF

Info

Publication number
NL8402904A
NL8402904A NL8402904A NL8402904A NL8402904A NL 8402904 A NL8402904 A NL 8402904A NL 8402904 A NL8402904 A NL 8402904A NL 8402904 A NL8402904 A NL 8402904A NL 8402904 A NL8402904 A NL 8402904A
Authority
NL
Netherlands
Prior art keywords
vac
chromatography
phospholipid
factor
activity
Prior art date
Application number
NL8402904A
Other languages
English (en)
Dutch (nl)
Original Assignee
Univ Limburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Limburg filed Critical Univ Limburg
Priority to NL8402904A priority Critical patent/NL8402904A/nl
Priority to DD85280751A priority patent/DD241691A5/de
Priority to KR1019850006891A priority patent/KR930007434B1/ko
Priority to NO853700A priority patent/NO164991C/no
Priority to PT81168A priority patent/PT81168B/pt
Priority to DE19853533516 priority patent/DE3533516A1/de
Priority to FI853611A priority patent/FI83882C/fi
Priority to JP60208573A priority patent/JPH0780912B2/ja
Priority to IE232385A priority patent/IE58862B1/en
Priority to CA000491206A priority patent/CA1244763A/en
Priority to IL76441A priority patent/IL76441A/xx
Priority to EP85111887A priority patent/EP0181465B2/de
Priority to ZA857222A priority patent/ZA857222B/xx
Priority to HU853552A priority patent/HU199883B/hu
Priority to AT85111887T priority patent/ATE45365T1/de
Priority to DK427485A priority patent/DK166587B1/da
Priority to DE8585111887T priority patent/DE3572179D1/de
Priority to NZ213563A priority patent/NZ213563A/xx
Priority to GR852300A priority patent/GR852300B/el
Priority to ES547139A priority patent/ES8702431A1/es
Priority to SU853957808A priority patent/SU1512473A3/ru
Priority to PH32821A priority patent/PH23942A/en
Priority to AU47682/85A priority patent/AU596951B2/en
Priority to US06/779,287 priority patent/US4736018A/en
Publication of NL8402904A publication Critical patent/NL8402904A/nl
Priority to US07/123,970 priority patent/US5066787A/en
Priority to US07/447,065 priority patent/US5066788A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8402904A 1984-09-21 1984-09-21 De bloedstolling remmend eiwitmateriaal, werkwijze voor het isoleren daarvan alsmede farmaceutisch preparaat. NL8402904A (nl)

Priority Applications (26)

Application Number Priority Date Filing Date Title
NL8402904A NL8402904A (nl) 1984-09-21 1984-09-21 De bloedstolling remmend eiwitmateriaal, werkwijze voor het isoleren daarvan alsmede farmaceutisch preparaat.
DD85280751A DD241691A5 (de) 1984-09-21 1985-09-18 Verfahren zur herstellung blutgerinnungshemmender proteine
HU853552A HU199883B (en) 1984-09-21 1985-09-20 Process for producing anticoagulant proteins and pharmaceutical compositions comprising same
DK427485A DK166587B1 (da) 1984-09-21 1985-09-20 Blodkoagulationshaemmende proteiner, fremgangsmaade til deres fremstilling samt deres anvendelse
PT81168A PT81168B (pt) 1984-09-21 1985-09-20 Processo para a preparacao de proteinas inibidoras da coagulacao do sangue e de composicoes farmaceuticas contendo estas substancias
DE19853533516 DE3533516A1 (de) 1984-09-21 1985-09-20 Blutgerinnungshemmende proteine, verfahren zur herstellung sowie deren verwendung
FI853611A FI83882C (fi) 1984-09-21 1985-09-20 Foerfarande foer framstaellning av blodlevring haemmande proteiner.
JP60208573A JPH0780912B2 (ja) 1984-09-21 1985-09-20 血液凝固抑止性タンパク質
IE232385A IE58862B1 (en) 1984-09-21 1985-09-20 Blood coagulation inhibiting proteins, processes for preparing them and their uses
CA000491206A CA1244763A (en) 1984-09-21 1985-09-20 Blood coagulation inhibiting proteins, processes for preparing them and their uses
IL76441A IL76441A (en) 1984-09-21 1985-09-20 Blood coagulation inhibiting proteins and their preparation
EP85111887A EP0181465B2 (de) 1984-09-21 1985-09-20 Blutgerinnungshemmende Proteine, Verfahren zur Herstellung sowie deren Verwendung
ZA857222A ZA857222B (en) 1984-09-21 1985-09-20 Blood coagulation inhibiting proteins,processes for preparing them and their uses
KR1019850006891A KR930007434B1 (ko) 1984-09-21 1985-09-20 혈액응고 억제 단백질 제조방법
AT85111887T ATE45365T1 (de) 1984-09-21 1985-09-20 Blutgerinnungshemmende proteine, verfahren zur herstellung sowie deren verwendung.
NO853700A NO164991C (no) 1984-09-21 1985-09-20 Fremgangsmaate for fremstilling av blodkoaguleringshemmende proteiner.
DE8585111887T DE3572179D1 (en) 1984-09-21 1985-09-20 Blood coagulation inhibiting proteins, process for preparing them and their use
NZ213563A NZ213563A (en) 1984-09-21 1985-09-20 Anticoagulant proteins and pharmaceutical compositions
GR852300A GR852300B (es) 1984-09-21 1985-09-20
ES547139A ES8702431A1 (es) 1984-09-21 1985-09-20 Procedimiento para preparar una proteina inhibidora de la coagulacion de la sangre
SU853957808A SU1512473A3 (ru) 1984-09-21 1985-09-20 Способ получени белков с мол.м. 32000-34000, подавл ющих свертывание крови
PH32821A PH23942A (en) 1984-09-21 1985-09-23 Blood coagulation inhibiting proteins,processes for preparing them and their uses
AU47682/85A AU596951B2 (en) 1984-09-21 1985-09-23 Blood coagulation inhibiting proteins, processes for preparing them and their uses
US06/779,287 US4736018A (en) 1984-09-21 1985-09-23 Blood coagulation inhibiting proteins, processes for preparing them and their uses
US07/123,970 US5066787A (en) 1984-09-21 1987-11-23 Blood coagulation inhibiting proteins, processes for preparing them and their uses
US07/447,065 US5066788A (en) 1984-09-21 1989-12-07 Blood coagulation inhibiting proteins, processes for preparing them and their uses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8402904 1984-09-21
NL8402904A NL8402904A (nl) 1984-09-21 1984-09-21 De bloedstolling remmend eiwitmateriaal, werkwijze voor het isoleren daarvan alsmede farmaceutisch preparaat.

Publications (1)

Publication Number Publication Date
NL8402904A true NL8402904A (nl) 1986-04-16

Family

ID=19844504

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8402904A NL8402904A (nl) 1984-09-21 1984-09-21 De bloedstolling remmend eiwitmateriaal, werkwijze voor het isoleren daarvan alsmede farmaceutisch preparaat.

Country Status (5)

Country Link
DD (1) DD241691A5 (es)
GR (1) GR852300B (es)
NL (1) NL8402904A (es)
SU (1) SU1512473A3 (es)
ZA (1) ZA857222B (es)

Also Published As

Publication number Publication date
GR852300B (es) 1986-01-21
SU1512473A3 (ru) 1989-09-30
DD241691A5 (de) 1986-12-24
ZA857222B (en) 1987-05-27

Similar Documents

Publication Publication Date Title
US4736018A (en) Blood coagulation inhibiting proteins, processes for preparing them and their uses
Reutelingsperger et al. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord
Koppelman et al. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII
Selak et al. Cathepsin G is a strong platelet agonist released by neutrophils
Kisiel et al. Proteolytic activation of protein C from bovine plasma
Kisiel et al. [26] Protein C
Reutelingsperger et al. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation: Inhibition of the phospholipid‐dependent factor‐Xa‐catalyzed prothrombin activation, through a high‐affinity binding of the anticoagulant to the phospholipids
Østerud et al. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X
JPH0689014B2 (ja) トロンビン結合性物質およびその製法
Oesterud et al. Activation of the coagulation factor VII by tissue thromboplastin and calcium
US5066788A (en) Blood coagulation inhibiting proteins, processes for preparing them and their uses
Kurosawa et al. Preparation of thrombomodulin from human placenta
Loskutoff et al. Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor
Chung et al. Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill.
US4473553A (en) Process for producing a lipoprotein-poor concentrate of coagulation factors VII and VIIa
JPH07115972A (ja) ヒト活性化プロテインｃ調製物及びその製法
Sie et al. Inactivation of heparin cofactor II by polymorphonuclear leukocytes
Walker et al. The molecular mechanisms of heparin action: III. The anticoagulant properties of polyanetholesulfonate
NL8402904A (nl) De bloedstolling remmend eiwitmateriaal, werkwijze voor het isoleren daarvan alsmede farmaceutisch preparaat.
NL8320346A (nl) Nieuwe plasminogeen-activator, werkwijze voor de bereiding daarvan, en thrombolytisch middel dat dit bevat.
Vasse et al. Protein C: Rouen, a new hereditary protein C abnormality with low anticoagulant but normal amidolytic activities
Barrowcliffe et al. Studies of the heterogeneity of antithrombin III concentrates
Cox Coagulation factor X inhibitor from hundred-pace snake (Deinagkistrodon acutus) venom
EP0239644A1 (en) Novel physiologically active substance having blood coagulation controlling activity
Clemmensen et al. Purification of a plasminogen activator inhibitor indistinguishable from α1-antitrypsin and an urokinase inhibitor in pregnancy plasma

Legal Events

Date Code Title Description
A1B A search report has been drawn up
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: BOEHRINGER INGELHEIM INTERNATIONAL GMBH

BC A request for examination has been filed
BV The patent application has lapsed